# Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer

> **NCT06020807** · — · COMPLETED · sponsor: **Nucleix Ltd.** · enrollment: 168 (actual)

## Conditions studied

- Non Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Urothelial Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** Bladder EpiCheck

## Key facts

- **NCT ID:** NCT06020807
- **Lead sponsor:** Nucleix Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-05
- **Primary completion:** 2020-01-08
- **Final completion:** 2020-01-08
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06020807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06020807, "Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06020807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*